Apella Capital LLC acquired a new stake in shares of Corteva, Inc. (NYSE: CTVA) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 7,646 shares of the company's stock, valued at approximately $517,000. Other hedge funds also recently bought and sold shares

Corteva (NYSE: CTVA - Get Free Report) and Dole (NYSE: DOLE - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations. Dividends Corteva pays an annual dividend of $0.72 per

Contravisory Investment Management Inc. grew its position in Corteva, Inc. (NYSE: CTVA) by 204.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,256 shares of the company's stock after purchasing an additional 9,581 shares during the

INDIANAPOLIS & MENLO PARK, Calif.--(BUSINESS WIRE)--Corteva (NYSE: CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. The partnership bring.

Cerity Partners LLC raised its position in shares of Corteva, Inc. (NYSE: CTVA) by 5.3% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 254,381 shares of the company's stock after purchasing an additional 12,873 shares

Brandes Investment Partners LP reduced its position in shares of Corteva, Inc. (NYSE: CTVA) by 20.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,335,741 shares of the company's stock after selling 609,739 shares during the quarter. Corteva

Avantax Advisory Services Inc. grew its position in shares of Corteva, Inc. (NYSE: CTVA) by 23.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,674 shares of the company's stock after purchasing an additional 4,853 shares during the quarter. Avantax Advisory

Bank Julius Baer and Co. Ltd Zurich reduced its stake in Corteva, Inc. (NYSE: CTVA) by 15.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 207,056 shares of the company's stock after selling 37,910 shares during the period. Bank

Bronte Capital Management Pty Ltd. lifted its position in Corteva, Inc. (NYSE: CTVA) by 13.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 647,820 shares of the company's stock after acquiring an additional 76,388 shares during the period. Corteva

17 Capital Partners LLC decreased its holdings in Corteva, Inc. (NYSE: CTVA) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 32,749 shares of the company's stock after selling 1,757 shares during the quarter. Corteva accounts for approximately 1.4%